ArticleBMC veterinary research2025
Comparative analysis of virulence genes, biofilm production, and antibiotic resistance in Escherichia coli from dogs and humans using rep-PCR.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEscherichia coli (E. coli) is a major pathogen responsible for urinary tract and gastrointestinal infections in both humans and dogs and is of serious public health concern due to its potential for severe infections. The aim of this study was to compare the pathogenicity of E. coli strains isolated from dogs and humans using repetitive sequence-based polymerase chain reaction (rep-PCR).
methodsA total of 30 fecal samples from visiting dogs and 30 samples from veterinarians and other animal-related personnel in Tehran and Qom, Iran was collected. The presence of E. coli was confirmed by phenotypic and biochemical methods (Gram staining, culture on MacConkey and EMB agar, TSI agar, and IMViC tests) followed by identification of virulence genes (bfpB, elt, stx1, hlyA, fimC) by PCR. Susceptibility to antimicrobials was determined using the Kirby-Bauer method and the ability to produce biofilm was assessed. Finally, all isolates were subjected to genomic fingerprinting using rep-PCR.
resultsOut of 60 fecal samples, only one E. coli isolate per sample was selected for analysis. All 60 isolates were confirmed and the fimC gene was present in all samples, while the bfpB gene was found in 90% of human samples and 46.4% of animal samples. All isolates had the ability to produce biofilm, with 20% of human samples and 56.6% of animal samples produced strong biofilms. Antimicrobial testing showed high resistance to amikacin (96.6-100%) and fluoroquinolones, but susceptible to nitrofurantoin and gentamicin. Over 90% of isolates were multidrug-resistant, indicating treatment challenges. Based on rep-PCR, the isolates are assigned to 12 different clusters. Of the 12 clusters identified, five contained isolates from both humans and dogs, suggesting potential zoonotic transmission.
conclusionsThe results suggest that E. coli from humans and dogs share the same pathogenic characteristics, with notable differences in biofilm production and antibiotic resistance. The genetic relatedness between some isolates highlights the risk of zoonotic transmission, emphasizing the need for continuous surveillance and a One Health approach to control infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.